Molecular cancer therapy: Epigallocatechin 3-Gallate (EGCG), the major component of Green tea, suppresses the expression of Interleukin-6 receptor (IL-6R) via down regulation of its target gene, 10/April/2014, 8.33 am

Molecular cancer therapy: Epigallocatechin 3-Gallate (EGCG), the major component of Green tea, suppresses the expression of Interleukin-6 receptor (IL-6R) via down regulation of its target gene, 10/April/2014, 8.33 am

Molecular cancer therapy: Epigallocatechin 3-Gallate (EGCG), the major component of Green tea, suppresses the expression of Interleukin-6 receptor (IL-6R) via down regulation of its target gene, 10/April/2014, 8.33 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated by: Dr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To cite: Boominathan, Molecular cancer therapy:  Epigallocatechin 3-Gallate (EGCG), the major component of Green tea,  suppresses the expression of Interleukin-6 receptor (IL-6R) via up regulation of its target gene, 10/April/2014, 8.33 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Share
Start Typing